Literature DB >> 1351387

Characterization of field isolates of suid herpesvirus 1 (Aujeszky's disease virus) as derivatives of attenuated vaccine strains.

L S Christensen1, I Medveczky, B S Strandbygaard, Z Pejsak.   

Abstract

Field isolates of suid herpesvirus 1 (Aujeszky's disease virus) from Poland and Hungary were identified by restriction fragment pattern analysis as derivatives of attenuated vaccine strains. The Polish isolates were found to be related to the BUK-TK-900 strain (Suivac A) which is widely used as a live vaccine in Poland, and the Hungarian isolates were related to the Bartha K-61 vaccine strain widely used in Hungary. Pigs experimentally infected with derivatives of BUK-TK-900 or BUK-TK-900 itself were found to develop gI-antibodies, while pigs infected with derivatives of Bartha K-61 showed a gI-negative response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351387     DOI: 10.1007/bf01309804

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Comparison by restriction fragment pattern analysis and molecular characterization of some European isolates of Suid herpesvirus 1: a contribution to strain differentiation of European isolates.

Authors:  L S Christensen
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 2.  Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies).

Authors:  S Kit
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

3.  Multiple defects in the genome of pseudorabies virus can affect virulence without detectably affecting replication in cell culture.

Authors:  B Lomniczi; A S Kaplan; T Ben-Porat
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

4.  Host cell-specific growth advantage of pseudorabies virus with a deletion in the genome sequences encoding a structural glycoprotein.

Authors:  T C Mettenleiter; B Lomniczi; N Sugg; C Schreurs; T Ben-Porat
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63.

Authors:  E A Petrovskis; J G Timmins; T M Gierman; L E Post
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

6.  Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication.

Authors:  F A Zuckermann; T C Mettenleiter; C Schreurs; N Sugg; T Ben-Porat
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Isolation of Aujeszky's disease virus from boar semen.

Authors:  I Medveczky; I Szabó
Journal:  Acta Vet Acad Sci Hung       Date:  1981

8.  Aujeszky's disease: blocking ELISA for the detection of serum antibodies.

Authors:  K J Sørensen; J C Lei
Journal:  J Virol Methods       Date:  1986-05       Impact factor: 2.014

9.  Virus reactivation in pigs latently infected with a thymidine kinase negative vaccine strain of pseudorabies virus.

Authors:  W L Mengeling
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Pseudorabies virus avirulent strains fail to express a major glycoprotein.

Authors:  T C Mettenleiter; N Lukàcs; H J Rziha
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

View more
  5 in total

1.  High frequency intergenomic recombination of suid herpesvirus 1 (SHV-1, Aujeszky's disease virus).

Authors:  L S Christensen; B Lomniczi
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.

Authors:  S Heffner; F Kovács; B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

3.  A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.

Authors:  Moriah L Szpara; Yolanda R Tafuri; Lance Parsons; S Rafi Shamim; Kevin J Verstrepen; Matthieu Legendre; L W Enquist
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

4.  Genotyping of the pseudorabies virus by multiplex PCR followed by restriction enzyme analysis.

Authors:  Antônio Augusto Fonseca; Cristina Gonçalves Magalhães; Erica Bravo Sales; Régia Maria D'Ambros; Janice Ciacci-Zanella; Marcos Bryan Heinemann; Rômulo Cerqueira Leite; Jenner Karlisson Pimenta Dos Reis
Journal:  ISRN Microbiol       Date:  2011-11-24

5.  Host antiviral protein IFITM2 restricts pseudorabies virus replication.

Authors:  Jingying Xie; Yingjie Bi; Shujuan Xu; Yumei Han; Adi Idris; Haixia Zhang; Xiangrong Li; Jialin Bai; Yong Zhang; Ruofei Feng
Journal:  Virus Res       Date:  2020-07-31       Impact factor: 3.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.